Research to Prevent Blindness

A Note from RPB President Brian F. Hofland, PhD

The past year has held difficult times for all of us. No matter what role we play (family member, friend, professional, etc.), we were challenged to come up with new ways to go about our lives and work, with fewer resources and more worries.

At RPB, which is based in New York City, we transitioned to telecommuting and are now preparing to come back into the office in a hybrid capacity in July 2021. I am proud to say that despite the difficulties we faced, RPB remained fully operational throughout the COVID-19 pandemic. Not only are did we run our full grants program, we continued to identify new ways to meet the needs of our vision science community.

It is often said that the only constant in life is change. Here at RPB we recognize that while our mission to develop treatments, preventives and cures for all diseases that threaten sight has remained steadfast over the years, it requires and is worthy of adaptation, time and time again.

I wish you and your loved ones health and well-being and I look forward to connecting (virtually or otherwise) with you over our shared dedication to preserving what our founder Jules Stein called “the magnificent gift of sight,” no matter the circumstances.


Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.